1,154
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway

, , , &
Pages 13280-13292 | Received 10 Nov 2021, Accepted 17 May 2022, Published online: 29 May 2022

References

  • Yao Q, Li Y, Pei Y, et al. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p. Bioengineered. 2022;13(1):1767–1778.
  • Luo X, Chen J, Song WX, et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008;88(12):1264–1277.
  • Ferrari S, Ruggieri P, Cefalo G, et al. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol. 2012;30(17):2112–2118.
  • Haghiralsadat F, Amoabediny G, Naderinezhad S, et al. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. Int J Nanomedicine. 2018;13:3853–3866.
  • Zhang QH, Hu QX, Xie D, et al. Ganoderma lucidum exerts an anticancer effect on human Osteosarcoma cells via suppressing the Wnt/β-catenin signaling pathway. Integr Cancer Ther. 2019;18:1534735419890917.
  • Kumavath R, Paul S, Pavithran H, et al. Emergence of cardiac glycosides as potential drugs: Current and future scope for cancer therapeutics. Biomolecules. 2021;11(9):1275.
  • Reddy D, Kumavath R, Ghosh P, et al. Lanatoside C induces G2/M cell cycle arrest and suppresses cancer cell growth by attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR signaling pathways. Biomolecules. 2019;9(12):792.
  • Morimoto M, Tatsumi K, Yuui K, et al. Convallatoxin, the primary cardiac glycoside in lily of the valley (convallaria majalis), induces tissue factor expression in endothelial cells. Vet Med Sci. 2021;7(6):2440–2444.
  • Zhang ZH, Li MY, Wang Z, et al. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer. Phytomedicine. 2020;68:153172.
  • Anderson SE, Barton CE. The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner. Mol Genet Metab Rep. 2017;13:42–45.
  • Kaushik V, Azad N, Yakisich JS, et al. Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers. Cell Death Discov. 2017;3(1):17009.
  • Goltzman D. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008;473(2):218–224.
  • Pitarresi JR, Norgard RJ, Chiarella AM, et al. PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. Cancer Discov. 2021;11(7):1774–1791.
  • Qu Z, Li S. Long noncoding RNA LINC01278 favors the progression of osteosarcoma via modulating miR-133a-3p/PTHR1 signaling. J Cell Physiol. 2020. DOI:10.1002/jcp.29582
  • Ho PW, Goradia A, Russell MR, et al. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo. Oncogene. 2015;34(22):2922–2933.
  • Li S, Dong Y, Wang K, et al. Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways. J Orthop Surg Res. 2017;12(1):168.
  • Lin YC, Haas A, Bufe A, et al. Wnt10b-GSK3β-dependent Wnt/STOP signaling prevents aneuploidy in human somatic cells. Life Sci Alliance. 2021;4(1):e202000855.
  • Han YL, Luo D, Habaxi K, et al. COL5A2 Inhibits the TGF-β and Wnt/β-Catenin signaling pathways to inhibit the invasion and metastasis of osteosarcoma. Front Oncol. 2022;12:813809.
  • Chu W, Cao L, Daokun G, et al. iNOS promotes the development of osteosarcoma via Wnt/β-catenin pathway. J Immunol Res. 2021;2021:4549221.
  • Shao S, Piao L, Wang J, et al. Tspan9 induces EMT and promotes osteosarcoma metastasis via activating FAK-Ras-ERK1/2 pathway. Front Oncol. 2022;12:774988.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
  • Lee J, Kang J-S, Nam LB, et al. Suppression of NRF2/ARE by convallatoxin sensitises A549 cells to 5-FU-mediated apoptosis. Free Radic Res. 2018;52(11–12):1416–1423.
  • Schneider NF, Geller FC, Persich L, et al. Inhibition of cell proliferation, invasion and migration by the cardenolides digitoxigenin monodigitoxoside and convallatoxin in human lung cancer cell line. Nat Prod Res. 2016;30(11):1327–1331.
  • Li S, Pei Y, Wang W, et al. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1. Biomed Pharmacother. 2019;114:108839.
  • Li S, Chen P, Zheng K, et al. β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells. Int J Biol Macromol. 2018;111:1255–1263.